Stay updated on Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial

Sign up to get notified when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T13:35:26.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T13:19:54.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 error, replacing the detailed study information with a simple error page.
    Difference
    20%
    Check dated 2026-09-19T18:28:39.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    No additions or deletions were provided in the changes data. As a result, there are no changes to describe for this page context.
    Difference
    0.1%
    Check dated 2026-09-12T17:13:05.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    No additions or deletions are present in the provided changes, so the study page text remains unchanged according to the input.
    Difference
    0.1%
    Check dated 2026-09-05T19:19:17.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    A funding attribution line '2017 ( U.S. NIH Grant/Contract )' was added to the study's official title area. The site revision was updated to v3.6.6, replacing the previous v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-29T21:48:38.000Z thumbnail image

Stay in the know with updates to Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.